Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Carbapenem-resistant Enterobacteriaceae Eradication
NCT05791396Phase 2Recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2024
- Primary completion
- Apr 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Enterobacteriaceae colonization, sponsored by Policlinico Gemelli. Started Feb 2024; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT05791396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05791396.